1. Home
  2. BWXT vs RGEN Comparison

BWXT vs RGEN Comparison

Compare BWXT & RGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BWXT
  • RGEN
  • Stock Information
  • Founded
  • BWXT 1867
  • RGEN 1981
  • Country
  • BWXT United States
  • RGEN United States
  • Employees
  • BWXT N/A
  • RGEN N/A
  • Industry
  • BWXT
  • RGEN Medical/Dental Instruments
  • Sector
  • BWXT
  • RGEN Health Care
  • Exchange
  • BWXT Nasdaq
  • RGEN Nasdaq
  • Market Cap
  • BWXT 15.4B
  • RGEN 6.5B
  • IPO Year
  • BWXT N/A
  • RGEN N/A
  • Fundamental
  • Price
  • BWXT $176.71
  • RGEN $119.75
  • Analyst Decision
  • BWXT Buy
  • RGEN Buy
  • Analyst Count
  • BWXT 10
  • RGEN 10
  • Target Price
  • BWXT $161.95
  • RGEN $163.78
  • AVG Volume (30 Days)
  • BWXT 1.1M
  • RGEN 706.1K
  • Earning Date
  • BWXT 11-03-2025
  • RGEN 11-11-2025
  • Dividend Yield
  • BWXT 0.57%
  • RGEN N/A
  • EPS Growth
  • BWXT 9.94
  • RGEN N/A
  • EPS
  • BWXT 3.21
  • RGEN N/A
  • Revenue
  • BWXT $2,864,520,000.00
  • RGEN $673,956,000.00
  • Revenue This Year
  • BWXT $17.06
  • RGEN $16.74
  • Revenue Next Year
  • BWXT $9.67
  • RGEN $13.86
  • P/E Ratio
  • BWXT $55.11
  • RGEN N/A
  • Revenue Growth
  • BWXT 10.13
  • RGEN 8.73
  • 52 Week Low
  • BWXT $84.21
  • RGEN $102.97
  • 52 Week High
  • BWXT $189.25
  • RGEN $182.52
  • Technical
  • Relative Strength Index (RSI)
  • BWXT 53.43
  • RGEN 50.04
  • Support Level
  • BWXT N/A
  • RGEN $112.73
  • Resistance Level
  • BWXT $171.85
  • RGEN $122.71
  • Average True Range (ATR)
  • BWXT 3.68
  • RGEN 4.63
  • MACD
  • BWXT -5.65
  • RGEN -0.46
  • Stochastic Oscillator
  • BWXT 98.68
  • RGEN 55.87

About BWXT BWX Technologies Inc.

BWX Technologies Inc is a specialty manufacturer and service provider of nuclear components, operating in two segments: Government Operations and Commercial Operations. The Government Operations segment produces naval nuclear reactors and fuel for the U.S. Naval Nuclear Propulsion Program, while the Commercial Operations segment designs and manufactures commercial nuclear steam generators, heat exchangers, pressure vessels, reactor components, and other auxiliary equipment, including containers for the storage of spent nuclear fuel and other high-level nuclear waste. The majority of the company's revenue comes from Government Operations, with sales principally in the United States, Canada, and other regions.

About RGEN Repligen Corporation

Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies. Its customers include biopharmaceutical companies, contract development and manufacturing organizations, or CDMOs, and other life science companies. It sells four main product categories: filtration (including fluid management) is the largest category and was 58% of 2024 revenue, while chromatography, proteins, and process analytics were 19%, 12%, and 9%, respectively. Customers in North America, Europe, and Asia Pacific contributed 44%, 37%, and 19% of revenue, respectively.

Share on Social Networks: